Trial Scorecards

Snapshot summaries of recent study results in cardiology.

Trial Scorecards

THEMIS

Cardiology Today, October 2019
Researchers evaluated the effect of twice-daily ticagrelor (Brilinta, AstraZeneca) on CV death, MI or stroke in patients with type 2 diabetes.
Trial Scorecards

ORION-11

Cardiology Today, October 2019
Evaluation of the efficacy, safety and tolerability of a subcutaneous injection of inclisiran (The Medicines Company).
Trial Scorecards

PARAGON-HF

Cardiology Today, October 2019
Assessment of sacubitril/valsartan (Entresto, Novartis) vs. valsartan in patients with HF with preserved ejection fraction.
Trial Scorecards

ISAR-REACT 5

Cardiology Today, October 2019
Assessment of safety and efficacy of ticagrelor (Brilinta, AstraZeneca) vs. prasugrel (Effient, Daiichi Sankyo/Eli Lilly) in patients with ACS for…
Trial Scorecards

ENTRUST-AF PCI

Cardiology Today, October 2019
Researchers assessed bleeding risk of edoxaban (Savasya, Daiichi Sankyo) plus a P2Y12 inhibitor vs. a vitamin K antagonist, a P2Y12 inhibitor and…
Trial Scorecards

DEFINE-HF

Cardiology Today, October 2019
Researchers compared dapagliflozin (Farxiga, AstraZeneca) vs. placebo for HF-specific biomarkers, symptoms, health status and quality of life in…
Trial Scorecards

COMPLETE

Cardiology Today, October 2019
Study of complete revascularization vs. no further revascularization in patients with STEMI and multivessel CAD who had successful culprit-lesion…
Trial Scorecards

DAPA-HF

Cardiology Today, October 2019
Researchers compared outcomes of dapagliflozin (Farxiga, AstraZeneca) vs. placebo in patients with HF with reduced ejection fraction with or without…
Trial Scorecards

RIPPAF

Cardiology Today, September 2019
Researchers assessed the effects of remote ischemic preconditioning on physiological parameters in patients with nonvalvular paroxysmal AF.
Trial Scorecards

RIKADA

Cardiology Today, September 2019
Researchers performed in-depth genetic and phenotypic characterization of children with primary cardiomyopathy and their first-degree family members.